#Nephpearls #NephSky #CKDMBD
👉🏼 pubmed.ncbi.nlm.nih.gov/38992521/
#Nephpearls #NephSky #CKDMBD
👉🏼 pubmed.ncbi.nlm.nih.gov/38992521/
#Nephpearls #NephSky
👉 shop.lww.com/Manual-of-Ne...
#Nephpearls #NephSky
👉 shop.lww.com/Manual-of-Ne...
bit.ly/34hZ6JU (FREE)
bit.ly/34hZ6JU (FREE)
Meet #Tenapanor!
It inhibits paracellular phosphate absorption by modulating NHE3 & tight junctions.
A novel way to tackle phosphorus! 🔬💊
#Nephrology #Hyperphosphatemia #Dialysis #HD
📖https://doi.org/10.1053/j.jrn.2024.07.003
Meet #Tenapanor!
It inhibits paracellular phosphate absorption by modulating NHE3 & tight junctions.
A novel way to tackle phosphorus! 🔬💊
#Nephrology #Hyperphosphatemia #Dialysis #HD
📖https://doi.org/10.1053/j.jrn.2024.07.003
Dr. A.J. Lowe and Dr. Tyler Larson, both internal medicien residents at UNMC, worked to answer that question with faculty mentor Dr. Prasanth Ravipati! #NKFClinicals
Dr. A.J. Lowe and Dr. Tyler Larson, both internal medicien residents at UNMC, worked to answer that question with faculty mentor Dr. Prasanth Ravipati! #NKFClinicals
doi.org/10.1016/j.kint.2026.03.018
#MedSky #NephSky #OpenAccess #cardiovasculardisease
doi.org/10.1016/j.kint.2026.03.018
#MedSky #NephSky #OpenAccess #cardiovasculardisease
https://www.nature.c...
https://www.nature.c...
In an open-label Phase 2 trial, oxylanthanum carbonate (OLC), a phosphate binder, was well tolerated and enabled serum phosphate concentration control in over 90% of patients with hyperphosphatemia and a low pill burden. Read more in #ASNCJASN:
kidney.pub/CJASN0780
In an open-label Phase 2 trial, oxylanthanum carbonate (OLC), a phosphate binder, was well tolerated and enabled serum phosphate concentration control in over 90% of patients with hyperphosphatemia and a low pill burden. Read more in #ASNCJASN:
kidney.pub/CJASN0780
#NephJC
#NephJC